Stay updated on Dolutegravir for HIV Treatment Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir for HIV Treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir for HIV Treatment Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A page software/interface revision indicator was updated from v3.5.2 to v3.5.3, without modifying the study’s displayed clinical information.
    Difference
    0.0%
    Check dated 2026-04-27T07:35:54.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    - Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-20T02:52:54.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision indicator updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-22T05:48:13.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T19:28:36.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing the previous v3.4.1. This update appears cosmetic and does not alter study content.
    Difference
    0.0%
    Check dated 2026-02-14T05:15:14.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page. This appears to be a backend/version update with no changes to the visible study information.
    Difference
    0.0%
    Check dated 2026-02-07T00:54:00.000Z thumbnail image

Stay in the know with updates to Dolutegravir for HIV Treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir for HIV Treatment Clinical Trial page.